ea0026p565 | Cardiovascular endocrinology and lipid metabolism | ECE2011
Patti A M
, Rizzo M
, Corrado E
, Coppola G
, Muratori I
, Novo G
, Rini G B
, Novo S
Background: The presence of the metabolic syndrome (MS) increases cardiovascular morbidity and mortality but few data is available on the outcome in subjects with the MS and subclinical atherosclerosis.Aim: We aimed to assess cardio- and cerebro-vascular events in subjects with MS and subclinical atherosclerosis.Methods: We followed-up for 5 years 339 subjects with asymptomatic carotid intima-media thickness >0.9 mm, of whom 13...